News Releases Year: All News201920182017201620152014 Items per page All News2550 Summary ToggleContraVir Pharmaceuticals Announces Publication of CRV431 Data from Experimental Model of Hepatitis B Summary Toggle June 11, 2019 View News Release > Summary ToggleContraVir Pharmaceuticals Sets the Stage for CRV431 Development in NASH with Positive Results from Second Model of Liver Fibrosis Summary Toggle June 6, 2019 View News Release > Summary ToggleContraVir Pharmaceuticals, Inc. Announces Reverse Stock Split Summary Toggle May 31, 2019 View News Release > Summary ToggleContraVir Pharmaceuticals Receives Positive Nasdaq Listing Decision Summary Toggle May 6, 2019 View News Release > Summary ToggleContraVir Pharmaceuticals to Present at the 2019 ThinkEquity Conference Summary Toggle April 29, 2019 View News Release > Summary ToggleContraVir Pharmaceuticals, Inc. Announces Pricing of $2.14 Million Public Offering Summary Toggle April 25, 2019 View News Release > Summary ToggleContraVir Pharmaceuticals to Present CRV431 Phase 1 Data at the International Liver Congress™ Summary Toggle April 11, 2019 View News Release > Summary ToggleContraVir Pharmaceuticals Announces Panel Participation at 31st Annual ROTH Conference Summary Toggle March 4, 2019 View News Release > Summary ToggleContraVir Pharmaceuticals Announces Adjournment of Annual Meeting of Stockholders Summary Toggle January 15, 2019 View News Release > Summary ToggleContraVir Pharmaceuticals to Present CRV431 Preclinical Data at the Anti-Fibrotic Drug Development Summit Summary Toggle November 27, 2018 View News Release > Pagination Current page 1 Page 2 Page 3 Page 4 … Next page Next Last page Last
